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crucial	 to	 monitor	 trends	 and	 situations	 of	 ART	 treatment	 imple‐
mented	in	a	country.	The	Japan	Society	of	Obstetrics	and	Gynecology	









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































     |  9ISHIHARA et Al.
(JSOG)	started	an	ART	registry	system	in	1986.	In	2007,	the	JSOG	
launched	an	online	registration	system	and	collected	cycle‐specific	




2  | MATERIAL S AND METHODS
Since	2007,	 the	JSOG	has	requested	all	participating	ART	clinics	
and	 hospitals	 to	 register	 cycle‐specific	 information	 for	 all	 treat‐
ment	 cycles.	 The	 information	 includes	 patient	 characteristics,	
information	on	ART	treatment,	and	pregnancy	and	obstetric	out‐
comes.	Details	on	 the	 information	 collected	 in	 the	 registry	have	
been	 reported	 previously.3	 For	 ART	 cycles	 conducted	 between	
January	 1	 and	 December	 31,	 2016,	 JSOG	 requested	 registra‐





was	 performed	 to	 investigate	 the	 characteristics	 and	 treatment	
outcomes	of	registered	fresh	and	frozen‐thawed	embryo	transfer	
(FET)	cycles.	The	number	of	registered	cycles,	egg	retrievals,	fresh	
embryo	 transfer	 (ET)	 cycles,	 freeze‐all	 embryos/oocytes	 cycles,	
pregnancies,	 and	neonates	were	 compared	with	 that	 in	 previous	
years.	The	characteristics	of	 the	 registered	cycles	and	 treatment	
outcomes	 were	 described	 for	 fresh	 and	 FET	 cycles.	 Treatment	
outcomes	included	the	pregnancy,	miscarriage	and	live	birth	rates,	
multiple	pregnancies,	pregnancy	outcomes	for	ectopic	pregnancy,	
intrauterine	pregnancy	 coexisting	with	 an	ectopic	pregnancy,	 ar‐
tificial	 abortion,	 stillbirth,	 and	 fetal	 reduction.	 Furthermore,	 the	





There	were	 604	 registered	ART	 facilities	 in	 2016,	 of	which	 603	
participated	in	the	ART	registration	system.	The	number	of	facili‐
ties	that	actually	implemented	ART	treatment	in	2016	was	587;	16	


















































































































































































































































































































































































































































































































































































































10  |     ISHIHARA et Al.
for	fresh	IVF,	fresh	ICSI,	and	FET	cycles	were	94	566,	161	262,	and	
191	962,	 respectively.	 The	 total	 number	 of	 freeze‐all	 embryos/
oocytes	cycles	showed	an	increasing	trend	both	for	IVF	and	ICSI	
cycles,	 and	 34	188/92	185	 IVF	 (37.1%)	 and	 70	387/159	214	 ICSI	
(44.2%)	cycles	used	freeze‐all	embryos/oocytes	in	2016,	resulting	

















formed	 at	 a	 rate	 of	 81.0%	with	 a	 pregnancy	 rate	 of	 20.8%.	 The	
miscarriage	rate	per	pregnancy	was	25.9%	for	IVF,	28.5%	for	ICSI	
using	 ejaculated	 sperm,	 and	 27.6%	 for	 ICSI	with	 TESE,	 resulting	
in	respective	live	birth	rates	per	ET	of	15.9%,	12.3%,	and	10.3%.	
Singleton	 pregnancy	 rate	 and	 live	 birth	 rate	 were	 97.0%	 and	
96.4%,	respectively.
The	 characteristics	 and	 treatment	 outcomes	 of	 the	 FET	 cy‐
cles	are	shown	in	Table	3.	There	were	190	541	registered	cycles,	
of	which	FET	was	performed	in	187	132	cycles	leading	to	62	434	
pregnancies	 (pregnancy	 rate	 per	 FET	=	33.4%).	 The	 miscarriage	
rate	 per	 pregnancy	 was	 26.5%,	 resulting	 in	 a	 23.0%	 live	 birth	
rate	per	ET.	Single	ET	was	performed	at	a	rate	of	82.7%,	and	the	
singleton	 pregnancy	 and	 live	 birth	 rate	 was	 96.7%	 and	 96.4%,	
respectively.




















F I G U R E  1  Age	distributions	of	registered	cycles,	different	subgroup	of	cycles	with	ET,	pregnancy,	and	live	birth.	Adapted	from	
the	Japan	Society	of	Obstetrics	and	Gynecology	assisted	reproductive	technology	Databook	2016	(http://plaza.umin.ac.jp/~jsog‐
art/2016data_20180930.pdf).	ET,	embryo	transfer
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4  | DISCUSSION
Using	the	current	Japanese	ART	registry	system,	this	study	dem‐
onstrated	 that	 the	 total	 number	 of	 registered	 ART	 cycles	 was	
447	790,	and	resultant	live	births	were	54	110,	accounting	for	one	
in	18.1	neonates	born	in	Japan	in	2016.	These	figures	are	the	larg‐
est	 since	 the	 registry	 started.	 Single	 ET	was	 performed	 at	 rates	
of	more	than	80%	for	both	fresh	and	frozen	cycles,	resulting	in	a	








No.	of	registered	cycles 89 857 24 754 133 709 2799 27 462 4220 255 828
No.	of	egg	retrieval 87 656 24 545 131 873 2796 27 454 4048 251 399
No.	of	fresh	ET	cycles 25 649 6499 30 917 899 27 ‐ 506 64 497
No.	of	freeze‐all	cycles 32 379 15 090 54 036 1261 0 395 1414 104 575
No.	of	cycles	with	pregnancy 5817 1555 5635 134 1 ‐ 85 13 227
Pregnancy	rate	per	ET	(%) 22.7 23.9 18.2 14.9 3.7 ‐ 16.8 20.5
Pregnancy	rate	per	egg	retrieval	(%) 6.6 6.3 4.3 4.8 3.7 ‐ 2.1 5.3
Pregnancy	rate	per	egg	retrieval	excluding	
freeze‐all	cycles(%)
10.5 16.4 7.2 8.7 3.7 ‐ 3.2 9.0
SET	cycles 21 199 5606 24 517 548 3 ‐ 365 52 238
Pregnancy	following	SET	cycles 4825 1372 4484 94 0 ‐ 65 10 840
Rate	of	SET	cycles 82.7% 86.3% 79.3% 61.0% 11.1% ‐ 72.1% 81.0%
Pregnancy	rate	following	SET	cycles 22.8% 24.5% 18.3% 17.2% 0.0% ‐ 17.8% 20.8%
Miscarriages 1508 357 1605 37 0 ‐ 24 3531
Miscarriage	rate	per	pregnancy 25.9% 23.0% 28.5% 27.6% 0.0% ‐ 28.2% 26.7%
Singleton	pregnanciesb 5518 1496 5318 121 1 ‐ 82 12 536
Multiple	pregnanciesb 181 31 170 3 0 ‐ 1 386
Twin	pregnanciesb 180 31 168 3 0 ‐ 1 383
Triplet	pregnanciesb 1 0 2 0 0 ‐ 0 3
Quadruplet	pregnanciesb 0 0 0 0 0 ‐ 0 0
Multiple	pregnancy	rate	(%)b 3.2 2.0 3.1 2.4 0.0 ‐ 1.2 3.0
Live	births 4078 1123 3806 93 1 ‐ 58 9159
Live	birth	rate	per	ET	(%) 15.9 17.3 12.3 10.3 3.7 ‐ 11.5 14.2
Total	number	of	neonates 4206 1155 3916 95 1 ‐ 59 9432
Singleton	live	births 3930 1090 3666 89 1 ‐ 57 8833
Twin	live	births 135 31 122 3 0 ‐ 1 292
Triplet	live	births 2 1 2 0 0 ‐ 0 5
Quadruplet	live	births 0 0 0 0 0 ‐ 0 0
Pregnancy	outcomes
Ectopic	pregnancies 68 26 77 1 0 ‐ 2 174
Intrauterine	pregnancies	coexisting	with	
ectopic	pregnancy
1 0 1 0 0 ‐ 0 2
Artificial	abortions 23 6 28 0 0 ‐ 1 58
Stillbirths 22 5 19 0 0 ‐ 0 46
Fetal	reductions 0 0 1 0 0 ‐ 0 1
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singleton	live	birth	rate	of	96%	in	total.	The	number	of	freeze‐all	
cycles	 increased,	 resulting	 in	a	 reduction	 in	 the	number	of	 fresh	
ET	 cycles.	 These	 results	 represent	 the	 latest	 clinical	 practice	 of	
ART	in	Japan.
One	potential	reason	for	the	rising	number	of	ART	cycles	is	the	
advancing	 age	 of	 patients	 receiving	ART.	 In	 the	 registered	 cycles,	
the	mean	age	of	registered	cycles	was	38.1	years	(SD	=	4.5),	which	








tients	 regarding	 the	association	between	age	and	probabilities	 for	
pregnancy	in	ART	is	essential.
Single	ET	was	performed	at	a	 rate	of	more	 than	80%	both	 for	
fresh	and	frozen	cycles,	which	is	the	highest	rate	in	the	world.1	Single	
ET	is	one	effective	way	to	prevent	adverse	perinatal	outcomes	re‐
lated	 to	 multiple	 births	 while	 maintaining	 a	 cumulative	 live	 birth	
rate.4	 In	2008,	 JSOG	recommended	 restricting	 the	number	of	ETs	
to	 one	 in	 order	 to	 prevent	multiple	 pregnancies,	 although	 double	
ET	was	allowed	for	women	over	35	years	of	age	or	for	women	who	
TA B L E  3  Characteristics	and	treatment	outcomes	of	frozen	cycles	in	assisted	reproductive	technology,	Japan,	2016
Variables FET Othersa Total
No.	of	registered	cycles 190 541 1222 191 763
No.	of	FET 187 132 1100 188 232
No.	of	cycles	with	pregnancy 62 432 294 62 726
Pregnancy	rate	per	FET	(%) 33.4 26.7 33.3
SET	cycles 154 801 849 155 650
Pregnancy	following	SET	cycles 53 130 230 53 360
Rate	of	SET	cycles	(%) 82.7 77.2 82.7
Pregnancy	rate	following	SET	cycles	(%) 34.3 27.1 34.3
Miscarriages 16 552 84 16 636
Miscarriage	rate	per	pregnancy	(%) 26.5 28.6 26.5
Singleton	pregnanciesb 59 472 257 59 729
Multiple	pregnanciesb 2020 12 2032
Twin	pregnanciesb 1979 11 1990
Triplet	pregnanciesb 38 1 39
Quadruplet	pregnanciesb 3 0 3
Multiple	pregnancy	rate	(%)b 3.3 4.5 3.3
Live	births 43 153 176 43 329
Live	birth	rate	per	FET	(%) 23.1 16.0 23.0
Total	number	of	neonates 44 484 178 44 662
Singleton	live	births 41 615 170 41 785
Twin	live	births 1412 4 1416
Triplet	live	births 15 0 15
Quadruplet	live	births 0 0 0
Pregnancy	outcomes
Ectopic	pregnancies 357 2 359
Intrauterine	pregnancies	coexisting	with	ectopic	pregnancy 1 0 1
Artificial	abortions 277 1 278
Stillbirths 175 2 177
Fetal	reduction 23 1 24
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experienced	recurrent	 implantation	failure.	As	a	 result,	 the	rate	of	








trial	 (RCT)	 in	China	 demonstrated	 that	 the	 freeze‐all	 strategy	 had	











The	strengths	of	 the	Japanese	ART	 registry	 system	 include	 its	





countries	 of	 the	 International	 Committee	 for	Monitoring	 Assisted	
Reproductive	 Technologies.1	 Since	 the	 Japanese	 ART	 registry	
system	has	such	a	significant	compliance,	the	next	step	for	improv‐




validity	of	 the	 registry,	 as	done	by	other	 countries.13,14	For	exam‐
ple,	by	maintaining	data	quality,	 the	United	States	 registry	system	
developed	a	patients’	and	clinicians’	platform	for	the	prediction	of	










80%,	 resulting	 in	 a	 96%	 singleton	 live	 birth	 rate.	Ongoing	 investi‐








F I G U R E  2  Pregnancy,	live	birth,	and	miscarriage	rates	according	to	patients’	age.	Adapted	from	the	Japan	Society	of	Obstetrics	and	
Gynecology	assisted	reproductive	technology	Databook	2016	(http://plaza.umin.ac.jp/~jsog‐art/2016data_20180930.pdf).	ET,	embryo	
transfer
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aSingleton,	 twin,	 triplet	 and	 quadruplet	 pregnancies	 were	 defined	 ac‐
cording	to	the	number	of	gestational	sacs	in	utero.	
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